Tami Livnat Selected Research

Anaphylaxis (Anaphylactic Shock)

1/2020

Allergy and inhibitors in hemophilia - a rare complication with potential novel solutions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tami Livnat Research Topics

Disease

29	Hemorrhage 01/2024 - 01/2006
19	Hemophilia A (Haemophilia) 01/2024 - 09/2009
9	Choroidal Neovascularization 06/2023 - 12/2010
5	Inflammation (Inflammations) 11/2022 - 01/2015
4	Hemophilia B (Haemophilia B) 01/2020 - 01/2017
4	Corneal Neovascularization 01/2019 - 01/2016
4	Thrombasthenia (Glanzmann Thrombasthenia) 01/2019 - 01/2012
4	Thrombosis (Thrombus) 12/2018 - 09/2009
3	von Willebrand Diseases (von Willebrand's Disease) 11/2023 - 01/2021
3	Retinal Detachment (Retinal Detachments) 08/2020 - 01/2017
3	Hypoxia (Hypoxemia) 02/2019 - 12/2010
3	Chemical Burns (Chemical Burn) 01/2019 - 01/2016
3	Thrombocytopenia (Thrombopenia) 12/2018 - 12/2009
3	Factor XI Deficiency (Hemophilia C) 08/2015 - 06/2003
2	Metrorrhagia (Spotting) 09/2021 - 01/2020
2	Hemarthrosis 01/2021 - 01/2017
2	Diabetic Retinopathy (Retinopathy, Diabetic) 08/2020 - 01/2017
2	Rupture 11/2017 - 01/2016
2	Myopia 04/2016 - 10/2014
2	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 01/2015
1	Disease Susceptibility (Diathesis) 11/2023
1	Epistaxis (Nosebleed) 11/2023
1	Noonan Syndrome (Female Pseudo-Turner Syndrome) 11/2023
1	COVID-19 01/2023
1	Uveitis 11/2022
1	Type 3 von Willebrand Disease 01/2021
1	Joint Diseases (Joint Disease) 01/2021
1	Wounds and Injuries (Trauma) 10/2020
1	Anaphylaxis (Anaphylactic Shock) 01/2020
1	Neonatal Alloimmune Thrombocytopenia 12/2018
1	Hypersensitivity (Allergy) 12/2018
1	Retinal Perforations 01/2018
1	Mycosis Fungoides 10/2017
1	Multiple Myeloma 01/2017
1	Retinal Diseases 01/2017
1	Ocular Hypertension (Glaucoma, Suspect) 01/2016

Drug/Important Bio-Agent (IBA)

13	Thrombin FDA Link 11/2023 - 09/2009
9	emicizumabIBA 08/2023 - 11/2019
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 12/2010
5	Factor VIII (Coagulation Factor VIII)IBA 08/2023 - 09/2018
5	Retinaldehyde (Retinal)IBA 11/2022 - 09/2007
5	recombinant FVIIa (rFVIIa)FDA Link 01/2020 - 09/2009
4	Blood Coagulation Factors (Coagulation Factor)IBA 11/2023 - 12/2009
4	Fibrinogen (Factor I)FDA Link 01/2022 - 01/2012
4	Proteins (Proteins, Gene)FDA Link 08/2020 - 01/2011
4	AntibodiesIBA 12/2018 - 12/2009
3	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2024 - 06/2003
3	Hemostatics (Antihemorrhagics)IBA 11/2023 - 01/2017
3	AnticoagulantsIBA 06/2023 - 01/2021
3	Factor VIIa (Activated Factor VII)IBA 01/2020 - 09/2009
3	afliberceptIBA 01/2019 - 01/2016
3	Retinal Pigments (Pigments, Visual)IBA 01/2016 - 12/2010
2	3K3A-APC proteinIBA 06/2023 - 11/2022
2	InflammasomesIBA 06/2023 - 11/2022
2	Factor VII (Proconvertin)IBA 05/2021 - 07/2012
2	Protein CIBA 01/2021 - 01/2019
2	Prothrombin (Factor II)IBA 01/2020 - 01/2017
2	Histone Deacetylase InhibitorsIBA 02/2019 - 07/2017
2	Factor IX (Coagulation Factor IX)FDA LinkGeneric 12/2018 - 09/2018
2	anti-inhibitor coagulant complexIBA 01/2018 - 01/2017
2	AutoantibodiesIBA 03/2017 - 12/2009
2	Bevacizumab (Avastin)FDA Link 07/2016 - 01/2016
2	Riboflavin (Vitamin B2)FDA LinkGeneric 04/2016 - 10/2014
2	Apolipoprotein E4IBA 01/2016 - 01/2015
2	Factor XIII (Coagulation Factor XIII)IBA 01/2014 - 01/2012
2	hypericinIBA 01/2011 - 09/2007
1	LipopolysaccharidesIBA 11/2022
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2022
1	Vitamin K FDA Link 01/2022
1	marstacimabIBA 01/2022
1	A-factor (Streptomyces)IBA 09/2021
1	AntithrombinsIBA 01/2020
1	Factor IXa (Coagulation Factor IXa)IBA 11/2019
1	Factor X (Stuart Factor)IBA 11/2019
1	Hematoxylin (Haematoxylon)IBA 01/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2019
1	Endothelial Growth FactorsIBA 01/2019
1	Betamethasone (Celestone)FDA Link 01/2019
1	Intravenous Immunoglobulins (IVIG)FDA Link 12/2018
1	IntegrinsIBA 12/2018
1	prothrombin complex concentrates (PPSB)IBA 12/2018
1	HydrogelsIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 10/2017
1	diethoxyphosphoryloxymethyl butanoateIBA 07/2017
1	Rituximab (Mabthera)FDA Link 03/2017
1	SaltsIBA 01/2017
1	Immunomodulating AgentsIBA 01/2017
1	SolutionsIBA 01/2017
1	CytokinesIBA 01/2017
1	antithrombin III-protease complexIBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017

Therapy/Procedure

15	Therapeutics 01/2024 - 01/2011
3	Operative Surgical Procedures 11/2023 - 09/2018
3	Minor Surgical Procedures (Minor Surgery) 11/2019 - 01/2017
3	Platelet Transfusion (Blood Platelet Transfusions) 01/2019 - 01/2018
1	Vitrectomy 08/2020
1	Aftercare (After-Treatment) 01/2019
1	Lasers (Laser) 11/2017
1	Immunomodulation 03/2017
1	Semiconductor Lasers 01/2016